Recent News

• 04.23.2025 - Rein Therapeutics Granted Two Patents Covering the Novel Formulation and Administration Methods of Dry Powder LTI-03 for the Treatment of Respiratory Diseases
• 04.23.2025 - Rein Therapeutics Granted Two Patents Covering the Novel Formulation and Administration Methods of Dry Powder LTI-03 for the Treatment of Respiratory Diseases
• 04.15.2025 - Rein Therapeutics Announces a Publication in Biomedicines on the Immunomodulatory and Anti-fibrotic Properties of a Caveolin-1-Related Peptide in IPF and PASC-F
• 04.15.2025 - Rein Therapeutics Announces a Publication in Biomedicines on the Immunomodulatory and Anti-fibrotic Properties of a Caveolin-1-Related Peptide in IPF and PASC-F
• 04.07.2025 - Rein Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
• 04.07.2025 - Rein Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
• 01.28.2025 - Brandon Folkes, CFA
• 01.28.2025 - Brandon Folkes, CFA
• 01.22.2025 - Kemp Dolliver, CFA
• 01.22.2025 - Kemp Dolliver, CFA

Recent Filings